<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01491945</url>
  </required_header>
  <id_info>
    <org_study_id>CP-0004</org_study_id>
    <nct_id>NCT01491945</nct_id>
  </id_info>
  <brief_title>Safety and Effectiveness Trial of the Ventana Fenestrated Stent Graft System</brief_title>
  <official_title>Prospective, Multicenter, Single Arm Safety and Effectiveness Trial of the Endologix Fenestrated Stent Graft System for the Endovascular Repair of Juxtarenal/Pararenal (JAA/PAA) Aneurysms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Endologix</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Endologix</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to determine if the Ventana Fenestrated Stent Graft System is
      safe and effective for the endovascular repair of juxtarenal or pararenal aortic aneurysms.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety</measure>
    <time_frame>30 Days</time_frame>
    <description>Major Adverse Events = all cause death; bowel ischemia; myocardial infarction; paraplegia; renal failure; respiratory complications of stroke; blood loss &gt;1000cc</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effectiveness</measure>
    <time_frame>1 Year</time_frame>
    <description>Treatment Success=Procedural technical success and absence of aneurysm rupture, conversion to open repair, Type I endoleak after 30 days, Type III endoleak, clinically significant migration; aneurysm enlargement; or secondary intervention for resolution of endoleak, limb occlusion, migration, aneurysm sac expansion and/or a device defect</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
    <time_frame>&gt;30 Days to 5 Years</time_frame>
    <description>Major Adverse Events = all cause death; bowel ischemia; myocardial infarction; paraplegia; renal failure; respiratory complications of stroke; blood loss &gt;1000cc</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distal Blood Flow</measure>
    <time_frame>Discharge to 5 Years</time_frame>
    <description>Ankle-brachial index measurements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal Dysfunction</measure>
    <time_frame>Discharge to 5 Years</time_frame>
    <description>eGFR reduction &gt;30% from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device Performance</measure>
    <time_frame>30 Days to 5 Years</time_frame>
    <description>Aortic, fenestrated, and renal stent graft integrity and patency; migration; endoleak; and aneurysm sac morphology</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Utility Outcomes</measure>
    <time_frame>At the time of the procedure</time_frame>
    <description>Clinical Utility Outcomes consists of: anesthesia time; fluoroscopy time; contrast volume; estimated blood loss; % requiring transfusion; procedure time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time in ICU</measure>
    <time_frame>In-Hospital</time_frame>
    <description>Number of hours spent in the intensive care unit (ICU)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Hospital Discharge</measure>
    <time_frame>Hospital Discharge (Post-Procedure)</time_frame>
    <description>Number of days from the index procedure to discharge from the hospital.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">122</enrollment>
  <condition>Abdominal Aortic Aneurysm</condition>
  <arm_group>
    <arm_group_label>Ventana Fenestrated Stent Graft System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ventana Fenestrated Stent Graft System</intervention_name>
    <description>The Ventana Fenestrated Stent Graft System consists of the following:
bifurcated stent graft, Ventana fenestrated proximal extension stent graft, and Xpand renal stent grafts</description>
    <arm_group_label>Ventana Fenestrated Stent Graft System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female at least 18 years old;

          -  Informed consent understood and signed and patient agrees to all follow-up visits;

          -  Have aortic aneurysm with maximum diameter ≥5.5cm, or between 4.5 and 5.5cm and
             rapidly expanding (&gt;0.5cm in six months), or &gt;50% larger than the normal aortic
             diameter

          -  Anatomically eligible for the Bifurcated System per the FDA-approved indications for
             use (IFU) and for the Fenestrated Stent Graft System:

               -  Adequate iliac/femoral access compatible with the required delivery systems

               -  Non-aneurysmal infrarenal aortic neck &lt;15mm in length;

               -  Most caudal renal artery to aortoiliac bifurcation length ≥70mm

               -  SMA to aortoiliac bifurcation length ≥90mm;

               -  Proximal non-aneurysmal aortic neck below the SMA with: diameter 18 to 34 mm;
                  length ≥15 mm; angle ≤60° to the aneurysm sac;

               -  Angle ≤60° (clock face) between the SMA and CA

               -  Renal arteries both distal to the SMA by ≤35mm, within 30mm of each other
                  axially, with 4 to 8mm lumen diameter, and with clock face angle of 90° to 210°
                  to each other .Common iliac artery distal fixation site with: distal fixation
                  length ≥15 mm; ability to preserve at least one hypogastric artery; diameter ≥10
                  mm and ≤23 mm; angle ≤90° to the aortic bifurcation.

          -  The Endologix Fenestrated Proximal Extension Stent must have the ability to overlap
             the bifurcated stent graft by at least 3cm.

          -  Aortic diameter at the most caudal renal artery of 18 to 36mm

        Exclusion Criteria:

          -  Life expectancy &lt;2 years as judged by the investigator;

          -  Psychiatric or other condition that may interfere with the study;

          -  Participating in the enrollment or 30-day follow-up phase of another clinical study;

          -  Known allergy to any device component;

          -  Coagulopathy or uncontrolled bleeding disorder;

          -  Contraindication to contrast media or anticoagulants;

          -  Ruptured, leaking, or mycotic aneurysm;

          -  Aortic dissection

          -  Serum creatinine (S-Cr) level &gt;2.0 mg/dL;

          -  Traumatic vascular injury;

          -  Active systemic or localized groin infection;

          -  Connective tissue disease (e.g., Marfan's Syndrome);

          -  Recent (within prior three months) cerebrovascular accident or myocardial infarction;

          -  Prior renal transplant;

          -  Length of either renal artery to be stented &lt;13mm;

          -  Significant occlusive disease of either renal artery (&gt;70% stenosis);

          -  An essential accessory renal artery;

          -  Indispensable inferior mesenteric artery;

          -  Aneurysmal disease of the descending thoracic aorta;

          -  Clinically significant mural thrombus circumferentially in the suprarenal segment;

          -  Prior iliac artery stent implanted that may interfere with delivery system
             introduction;

          -  Unsuitable vascular anatomy;

          -  Pregnancy (female patient of childbearing potential only)

          -  Existing renal stent;

          -  Pre-planned need for concomitant procedure (e.g. surgical conduit for vascular access,
             hypogastric artery embolization/coil, renal artery angioplasty)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel G Clair, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35429</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arizona Heart Institute</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John Muir Medical Center Concord, CA</name>
      <address>
        <city>Concord</city>
        <state>California</state>
        <zip>94520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCLA Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Gainesville</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baptist East Hospital</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barnes-Jewish Hospital</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dartmouth-Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of North Carolina</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UPMC</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harborview Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charleston Area Medical Center</name>
      <address>
        <city>Charleston</city>
        <state>West Virginia</state>
        <zip>25304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aurora St. Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 20, 2011</study_first_submitted>
  <study_first_submitted_qc>December 12, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2011</study_first_posted>
  <last_update_submitted>August 20, 2015</last_update_submitted>
  <last_update_submitted_qc>August 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Abdominal aortic aneurysm</keyword>
  <keyword>Renal stent</keyword>
  <keyword>Juxtarenal</keyword>
  <keyword>Pararenal</keyword>
  <keyword>Endovascular</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

